New sequencing technology to increase the diagnostic accuracy for ABCA4 related-disease
Association for Research in Vision and Ophthalmology (ARVO)New research being presented at the virtual 2021 Annual Meeting of The Association for Research in Vision and Ophthalmology (ARVO) unveils an Oxford Nanopore long-range sequencing assay as a novel, low-cost approach for phasing biallelic mutations in the ABCA4 gene, which is responsible for a range of inherited blinding retinal diseases.